* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Developmental Mechanisms Underlying Polydactyly
Saethre–Chotzen syndrome wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Ridge (biology) wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Cancer epigenetics wikipedia , lookup
X-inactivation wikipedia , lookup
Oncogenomics wikipedia , lookup
Epigenetics of depression wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Genomic imprinting wikipedia , lookup
Genetic engineering wikipedia , lookup
Point mutation wikipedia , lookup
Public health genomics wikipedia , lookup
Gene desert wikipedia , lookup
Genome evolution wikipedia , lookup
Gene nomenclature wikipedia , lookup
Long non-coding RNA wikipedia , lookup
Gene therapy wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
History of genetic engineering wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Genome (book) wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Microevolution wikipedia , lookup
Gene expression profiling wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Gene expression programming wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
72P Medical Research Society M209 Genetic Studies of a Novel Cleft Palate Gene. MSU Hassan, DT.Bonthron, A F Markhaa Cleft Palate(CP) is common affecting 1 in 650 newborns. Many studies confirm a major genetic contribution to the aetiology of CP. However, only for a small number of rare syndromes have disease CP-causing mutations been identified. Two lines of evidence suggest that an important CP locus exists at 2q32-q33. Firstly statistical analysis of malformations in patients with segmental chromosomal deletions shows a strong association of CP with this region. Secondly, our study of two patients who had de novo balanced reciprocal translocations at t(2;7)(q32;p21) and t(2;l l)(q32;p14) where CP was their only major malformation. These patients offered the possibility of homing in on the 2q CP locus by cloning the (possibly) common breakpoints on chromosome 2. A contig of PAC clones spanning the region(JOOkb) between the two breakpoints has been constructed. The sequencing of this region has now been completed and we have identified only one definite gene, which encodes a large protein with several DNA-binding domains that appears to be a transcriptional regulator. I have identified that this genes ten exons span the entire interval between the two patients breakpoints, so that this gene's function is disrupted in both patients. The introns are large, but sequence data has been obtained allowing PCR-based mutation screening of all coding exons. Since there are few or no other genes in the breakpoint interval, I feel it is highly likely that haploinsufficiency of this gene is indeed responsible for CP in the two patients. Over the last eighteen months I have designed and optimised methods for amplifying each exon of the candidate gene and begun to perform mutation screening in patients with isolated CP. To date, I've recruited 56 patients and intensive mutation detection on their genomic DNA samples is well underway. Patient recruitment is on going. The next stages of my work will involve exploring the following aspects of my candidate gene: (1) the orthologous murine gene, which we have now cloned and sequenced, will be inactivated by homologous recombination in order to explore the effects of haploinsufficiency in an animal model. (2) the development and spatial pattern of expression will be determined by in siru hybridisation. (3) Protein work to define the DNA-binding specificity and interaction profile to provide insights into the precise cellular targets for this putative transcriptional regulator. M210 Developmental Mechanisms Underlying Polydactyly Miss A Crick,'" J h . JM Brown' and Prof. GM Morriss-Kay' 'Department of Human Anatomy & Genetics, University of Oxford and *Department of Plastic Surgery, The Radcliffe Infirmary, Oxford. The anteroposterior (AP) axis of the limb is characterised in human and mouse by an anterior biphalangeal digit and four posterior triphalangeal digits.This AP pattern is thought to be determined by a diffusible morphogen emanating from a region of posterodistal limb bud mesenchyme called the zone of polarising activity (ZPA). The ZPA is defined by its ability to induce digit duplications when grafted anteriorly into a chick limb bud in ovo. The gene Sonic hedgehog (Shh)is a good candidate for this putative morphogen: expression co-localises with the ZPA and ectopic (anterior) expression has been detected in several mouse mutants with pre-axial polydactyly. The polydactylous mouse mutant Doublefool (Dbfl is exceptional in showing normal Shh expression although it has 6-8 triphalangeal digits per limb. However, genes down-stream of Shh including its own receptor and direct transcriptional target, Patched ( P r d ) , which in the wild-type all have posterior domains of expression, are all ectopically expressed throughout the distal limb bud mesenchyme in DbJ Grafts of posterior, mid-distal and anterior Dbf limb bud mesenchyme into anterior chick limb buds in ovo all induce digit duplications. Thus, there. is ectopic polarizing activity and activation of the Shh pathway in the absence of ectopic expression of Shh itself. Indian hedgehog (Ihh), is another of the three vertebrate homologues of the Drosophila gene, hedgehog and is normally associated with patterning of the cartilage anlagen later in development of the limb. The Ihh locus is within the 0.4cM Dbf region mapped to mouse chromosome 1. We have shown that Ihh is precociously and ectopically expressed throughout the distal limb bud mesenchyme in Dbfand that this pattern of expression correlates spatially and temporally with the ectopic polarizing activity and activation of the hedgehog pathway. Analysis of the developmental mechanisms underlying polydactyly in this mouse mutant has identified a candidate gene worthy of investigation in patients with congenital limb abnormalities, the majority of whom continue to have no genetic diagnosis. M211 Identifieaton and utilisation of the ORF 73 latency-associated regulatory region in Herpesvirus saimiri-based vectors Mathew Giles, Peter Smith, Whitehouse Kersten Hall and Adrian Molecular Medicine Unit, University of Leeds, St. James's University Hospital, Leeds, LS9 7TF Herpesvirus saimiri (HVS) is an attractive candidate for use as a gene therapy vector. HVS can efficiently infect a wide variety of human carcinoma cell lines without cytopathic effects. Moreover, the HVS viral DNA is clearly able to establish a latent episomal state within human cells and segregate to progeny upon cell division, a combination of characteristics which is not possessed by any other herpesvirus. At present, the first generation HVS vectors utilize heterologous promoters such as the CMV immediate early promoters. However, these promoters maybe unsuitable for long term expression in vivo, as promoter silencing has been observed in other herpesvirus-based vector systems. Therefore, alternative promoters to maintain long term expression in HVS vectors are required. Ideal promoters would function in a viral latent state. Here we describe the identification of a cluster of genes encoding ORF 71-73, which are latently expressed in an A549 cell line stably transduced by HVS-GFP. Moreover, these genes are transcribed as a polycistronic mRNA species from a common latency-associated promoter upstream of ORF 73. Utilising deletion analysis we have identified the minimal latency-associatedpromoter which we believe will be sufficient to drive long term therapeutic gene expression in HVS-based vectors. To test this hypothesis we have produced a recombinant HVS which incorporates the minimal latency-associated promoter elements expressing GFP.Upon infection of a wide range of carcinoma cell lines, the recombinant virus remains as a circular non-integrated circular episome allowing expression of the transgene from the latency-associated promoter. Furthermore, human cancer cell xenograft experiments have demonstrated that this promoter is functional in an in vivo environment. Therefore, we believe that the ORF 73 promoter is an ideal choice of regulatory sequence for driving stable long term expression of a transgene in HVS-based gene delivery vectors.